Prescription drug coupons: Evolution and need for regulation in direct-to-consumer advertising

Research in Social and Administrative Pharmacy

Volumn 10, Issue 3, 2014, Pages 588-594

  Mackey, Tim K ^a,b   Yagi, Nozomi ^c   Liang, Bryan A ^b  

^a CALIFORNIA WESTERN SCHOOL OF LAW   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Direct to consumer advertising; Drug coupons; Drug expenditures; Health law; Health policy

Indexed keywords

PRESCRIPTION DRUG;

DRUG LEGISLATION; DRUG UTILIZATION; FEE; HUMAN; LEGISLATION AND JURISPRUDENCE; MARKETING; MOTIVATION;

DRUG UTILIZATION; HUMANS; LEGISLATION, DRUG; MARKETING; MOTIVATION; PRESCRIPTION DRUGS; PRESCRIPTION FEES;

EID: 84900512833     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2013.08.002     Document Type: Note

References (36)

1. Liang B.A., Mackey T. Confronting conflict: addressing institutional conflicts of interest in academic medical centers. Am J Law Med 2010, 36:136-187.
2. Gagnon M.A., Lexchin J. The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States. PLoS Med 2008, 5:e1.
3. Greene J.A. Pharmaceutical marketing research and the prescribing physician. Ann Intern Med 2007, 146:742-748. http://dx.doi.org/10.7326/0003-4819-146-10-200705150-00008.
4. Steinman M.A., Landefeld C.S., Baron R.B. Industry support of CME - are we at the tipping point?. N Engl J Med 2012, 366:1069-1071. http://dx.doi.org/10.1056/NEJMp1114776.
5. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift?. JAMA 2000, 283:373-380.
6. Mackey T.K., Liang B.A. Physician payment disclosure under health care reform: will the sun shine?. J Am Board Fam Med 2013, 26:327-331. http://dx.doi.org/10.3122/jabfm.2013.03.120264.
7. Liang B.A., Mackey T. Reforming direct-to-consumer advertising. Nat Biotechnol 2011, 29:397-400. http://dx.doi.org/10.1038/nbt.1865.
8. Liang B.A., Mackey T.K. Prevalence and global health implications of social media in direct-to-consumer drug advertising. J Med Internet Res 2011, 13:e64. http://dx.doi.org/10.2196/jmir.1775.
9. Palumbo F.B., Mullins C.D. The development of direct-to-consumer prescription drug advertising regulation. Food Drug Law J 2002, 57:423-443.
10. Mackey T., Liang B. Globalization, evolution and emergence of direct-to-consumer advertising: are emerging markets the next pharmaceutical marketing frontier. J Commerc Biotechnol 2012, 18:58-64.
11. Mackenzie F.J., Jordens C.F.C., Ankeny R.A., McPhee J., Kerridge I.H. Direct-to-consumer advertising under the radar: the need for realistic drugs policy in Australia. Intern Med J 2007, 37:224-228. http://dx.doi.org/10.1111/j.1445-5994.2006.01298.x.
12. Mintzes B., Barer M.L., Kravitz R.L., et al. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. CMAJ 2003, 169:405-412.
13. Frosch D.L., Grande D., Tarn D.M., Kravitz R.L. A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising. Am J Public Health 2009, 100:24-32. http://dx.doi.org/10.2105/AJPH.2008.153767.
14. Liang B.A., Mackey T. Direct-to-consumer advertising with interactive internet media: global regulation and public health issues. JAMA 2011, 305:824-825. http://dx.doi.org/10.1001/jama.2011.203.
15. Mackey T.K., Liang B.A. Global reach of direct-to-consumer advertising using social media for illicit online drug sales. J Med Internet Res 2013, 15:e105. http://dx.doi.org/10.2196/jmir.2610.
16. Fox S. Pew Internet: Health, 2013. Available at: . Accessed 14.02.13. http://pewinternet.org/Commentary/2011/November/Pew-Internet-Health.aspx.
17. Park M. Coupon Culture Extends to Prescription Meds, 2012. Available at: . Accessed 06.08.13. http://www.cnn.com/2010/HEALTH/04/20/prescription.medicine.coupons/index.html.
18. Grande D. The cost of drug coupons. JAMA 2012, 307:2375-2376. http://dx.doi.org/10.1001/jama.2012.5603.
19. Bhutada N.S., Cook C.L., Perri M. Consumers responses to coupons in direct-to-consumer advertising of prescription drugs. Health Mark Q 2009, 26:333-346. http://dx.doi.org/10.1080/07359680903315902.
20. Visante. How Co-pay Coupons Could Raise Prescription Drug Costs by $32 Billion Over the Next Decade, 2011. Available at: . Accessed 08.08.13. http://www.masspirg.org/sites/pirg/files/reports/MASSPIRGvisante-co-pay-couponstudy.pdf.
21. Johnson LA. Coupons for Brand-Name Medicines Aim to Keep People Off Generic Drugs, 2012. Available at: . Accessed 19.11.12. http://www.huffingtonpost.com/2012/08/21/coupons-brand-name-medicine-generic-drugs-pfizer_n_1818179.html.
22. Faris P. Apps CouldMeanCheaper Prescription Drugs at Your Fingertips, 2013. Available at: . Accessed 06.08.13. http://abcnews.go.com/blogs/health/2013/03/05/apps-couldmean-cheaper-prescription-drugs-at-your-fingertips/.
23. Physicians Interactive and McKesson Announce Partnership to Provide eCoupon_Solution, 2012. Available at: . Accessed 13.12.12. http://www.physiciansinteractive.com/news/physicians-interactive-and-mckesson-announce-partnership-to-provide-ecoupon-solution/.
24. Johnson LA. Consumer Group Sues 8 Drugmakers Over Drug Coupons, 2012. Available at: . Accessed 08.03.12. http://www.usatoday.com/money/industries/health/drugs/story/2012-03-07/drug-coupons-lawsuit/53400686/1.
25. King S. The Best Selling Drugs of All Time; HumiraJoins the Elite, 2013. Available at: . Accessed 30.04.13. http://www.forbes.com/sites/simonking/2013/01/28/the-best-sellingdrugs-of-all-time-humira-joins-the-elite/.
26. Jackevicius C.A., Chou M.M., Ross J.S., Shah N.D., Krumholz H.M. Generic atorvastatin and healthcare costs. N Engl J Med 2012, 366:201-204. http://dx.doi.org/10.1056/NEJMp1113112.
27. Gill L., Santa J., Peter D.L., Keehn J. Lipitor goes generic: business as usual or more big business?. Ann Intern Med 2012, 156(12):892-893. http://dx.doi.org/10.7326/0003-4819-156-12-201206190-00420.
28. Don't Get Hooked on Prescription-Drug Coupons, 2012. Available at: . Accessed 06.08.13. http://www.consumerreports.org/cro/2012/03/don-t-get-hooked-on-prescriptiondrug-coupons/index.htm.
29. Office of Prescription Drug Promotion (OPDP) Research. FDA Website. Available at: . Accessed 06.08.13. http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm090276.htm.
30. Gourville J.T., Soman D. The consumer psychology ofmail-in rebates. J Product Brand Manage 2011, 20:147-157. http://dx.doi.org/10.1108/10610421111121143.
31. Experian. The Coupon Report: Benchmark Dataand Analysis for E-Mail Marketers, 2009. Available at: . Accessed 30.04.13. http://www.experian.com/assets/marketing-services/white-papers/EMS_coupon_report_WP.pdf.
32. Moeller P. Generic Drug Savings in 2012 MedicarePlans, 2011. Available at: . Accessed 19.03.12. http://money.usnews.com/money/blogs/the-best-life/2011/10/04/genericdrug-savings-in-2012-medicare-plans.
33. Lazar K. New Massachusetts Law Allows DiscountCoupons for Prescription Drugs, 2012. Available at: . Accessed 19.11.12. http://www.bostonglobe.com/lifestyle/health-wellness/2012/07/29/new-massachusetts-law-allows-discountcoupons-for-prescription-drugs/YXJdBcxhMMn0XqZfPKi56M/story.html.
34. Frieden J. Rx Drug Coupons Costly for Medicare, 2012. Available at: . Accessed 27.04.12. http://www.medpagetoday.com/PublicHealthPolicy/Medicare/32203.
35. Court Dismisses Challenge to Prescription Drug Copayment Coupon Program, 2013. Available at: . Accessed 06.08.13. http://www.hunton.com/files/News/7e5e25a2-c42b-45a0-b843-2ca2b1138f0e/Presentation/NewsAttachment/44d03c4e-da97-46b0-80f5-3118c84187fb/Court_Dismisses_Challenge_to_Prescription_Drug_Co-payment_Coupon_Program.pdf.
36. Liang B.A., Mackey T. Health care policy. Reforming off-label promotion to enhance orphan disease treatment. Science 2010, 327(5963):273-274. http://dx.doi.org/10.1126/science.1181567.